Article Details
Retrieved on: 2018-02-21 09:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Summit Therapeutics logo <b>Acadian Asset Management</b> LLC increased its position in shares of Summit Therapeutics PLC (NASDAQ:SMMT) by 192.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 144,083 shares of the company's stock after ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here